Children, Families, and Disparities: Pediatric Provisions in the Affordable Care Act

Aimee M Grace1, Ivor Horn2, Robert Hall3

  • 1Office of US Senator Brian Schatz, 722 Hart Senate Office Building, Washington, DC 20510, USA; George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037, USA.

Insights

The Affordable Care Act significantly impacts the U.S. health system, especially for children and families. This law addresses healthcare disparities and coverage within the American health sector.

Area of Science:

  • Health Policy and Law
  • Public Health
  • Healthcare Disparities

Background:

  • The U.S. healthcare system faces ongoing transformation.
  • The Affordable Care Act (ACA) introduced significant legislative changes.
  • Understanding the ACA's impact on vulnerable populations is crucial.

Purpose of the Study:

  • To summarize the Affordable Care Act.
  • To analyze the ACA's effects on children, families, and health disparities.
  • To provide context on the U.S. healthcare coverage system.

Main Methods:

  • Literature review of the Affordable Care Act.
  • Analysis of policy impacts on specific demographics.
  • Synthesis of current healthcare coverage landscape.

Main Results:

  • The ACA has initiated substantial changes in U.S. healthcare.
  • Focus areas include children's health, family coverage, and reducing disparities.
  • The law's complexity and ongoing definition present challenges.

Conclusions:

  • The Affordable Care Act is a landmark legislation reshaping American healthcare.
  • Its long-term effects on children, families, and health equity require continued monitoring.
  • The ACA's implementation necessitates clear communication and regulatory clarity.

Related Concept Videos

Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.3K
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
750
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337